CaseReport
Conservative treatment of ameloblastoma in mandible:
case report
CAMILA LOPES GONÇALVES1 | FELIPE EDUARDO BAIRES CAMPOS1 | LUIZ FELIPE CARDOSO LEHMAN1 | ROBERTA RAYRA MARTINS CHAVES2 | FLÁVIA LEITE LIMA1 | WAGNER HENRIQUES DE CASTRO1
ABSTRACT Ameloblastomas are slow-growing benign odontogenic tumors, locally invasive, that can reach varied proportions according to the time of evolution. The treatment of ameloblastomas has been controversial among surgeons. A patient with ameloblastoma in the mandible, treated by resection with conservative safety margin and of adjuvant therapies. After 4 years of follow-up without recurrence, the surgical defect reconstruction was performed by means of autogenous free graft from iliac crest and implant-supported dental prosthesis. After 9 years of follow up, the patient has no signs of recurrence and no esthetic and functional changes. Keywords: Ameloblastoma. Mandibular reconstruction. Mouth rehabilitation. Conservative treatment.
Universidade Federal de Minas Gerais, Programa de Residência em Cirurgia e Traumatologia Bucomaxilofacial, Hospital das Clínicas (Belo Horizonte/MG, Brazil).
1
How to cite: Gonçalves CL, Campos FEB, Lehman LFC, Chaves RRM, Lima FL, Castro WH. Conservative treatment of ameloblastoma in mandible: case report. J Braz Coll Oral Maxillofac Surg. 2019 Sept-Dec;5(3):45-50. DOI: https://doi.org/10.14436/2358-2782.5.3.045-050.oar
Universidade Federal de Minas Gerais, Programa de Mestrado em Estomatologia (Belo Horizonte/MG, Brazil).
2
Submitted: 20/03/2018 - Revised and accepted: 03/09/2018 » The authors report no commercial, proprietary or financial interest in the products or companies described in this article. » Patients displayed in this article previously approved the use of their facial and intraoral photographs. Contact address: Camila Lopes Gonçalves Av. Marechal Mascarenhas de Moraes, 607, apto. 702, Centro – Vitória/ES CEP: 29.010-330 – E-mail: camila_clg@hotmail.com
© Journal of the Brazilian College of Oral and Maxillofacial Surgery
45
J Braz Coll Oral Maxillofac Surg. 2019 Sept-Dec;5(3):45-50